Rexnord (RXN) Tops Q4 EPS by 2c, Beats on Revenues; Offers FY18 Outlook

Rexnord (NYSE: RXN) reported Q4 EPS of $0.35, $0.02 better than the analyst estimate of $0.33. Revenue for the quarter came in at $504 million versus the consensus estimate of $493.64 million.

Fiscal 2018 Outlook

Adams continued, “Our initial outlook for fiscal 2018 is based on the assumption of low single-digit core growth for the full year. We also expect to deliver the savings from our cost reduction programs and solid operating leverage on our sales growth, partially offset by growth investments and some incremental incentive compensation. We expect our GAAP net income(2) to be in a range of $87 million to $107 million, our Adjusted EBITDA(1) to be in a range of $365 million to $385 million, and our free cash flow to exceed net income.

Fourth Quarter Highlights

• Net sales were $504 million and up 2% year over year. Core sales(1) were flat, excluding a 2% impact from the Rodney Hunt Fontaine (“RHF”) product line exit. Acquisitions contributed 4% to net sales.
• Diluted EPS was $0.21, compared with $0.00 in the prior year.
• Net income(2) was $22 million.
• Adjusted EPS(1) was $0.35, compared with $0.37 in the prior year.
• Adjusted EBITDA(1) was $98 million, or 19.5% of net sales.
• Net debt(1) leverage ratio reduced to 3.1x.

For earnings history and earnings-related data on Rexnord (RXN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform